Le Lézard
Classified in: Health
Subject: SVY

The global liver treatment market is expected to reach US$ 4,883.5 Mn in 2025 from US$ 3,426.8 in 2017


NEW YORK, March 26, 2019 /PRNewswire/ -- The global liver treatment market is expected to reach US$ 4,883.5 Mn in 2025 from US$ 3,426.8 in 2017. The liver treatment market is estimated to grow with a CAGR of 4.6% from 2018-2025.

Read the full report: https://www.reportlinker.com/p05626750/?utm_source=PRN

Liver is an organ that is situated just below the rib cage and on the right side of the abdomen.As essential function of liver is to carry out digestion of food and ridding off the body from toxic substances.

A liver disease can either be inherited or may occur due to various factors such as, viruses or excessive consumption of alcohol.Over the time, damage to the liver results in scarring, a condition known as liver cirrhosis.

The condition of liver can be diagnosed by methods such as, blood tests, tissue analysis and imaging tests.The imaging modalities covered in the report include, magnetic resonance imaging (MRI), computed tomography (CT) and ultrasound.

Key factors such as increasing prevalence of liver diseases, rising geriatric population suffering from liver diseases and various technological advancements in imaging techniques are key drivers for the growth of the market. However, factors such as stringent regulatory framework and high cost of imaging techniques for liver treatment are likely to restrain the market growth to a certain extent. On the other side, owing the benefits offered by the hybrid imaging systems over the standalone ones, its use is anticipated to one of the prevalent trend considerably over the forecast period.

The disease segment of the liver treatment market is segmented into open cancer.Hepatitis, cirrhosis, and others.

In 2017, cancer held the largest market share.There has been a significant increase in the number of liver cancer cases due to hepatitis infections, smoking, over consumption of alcohol, and obesity.

The segment is anticipated to grow with a CAGR of 5.2% during the forecast period.
The imaging modality segment of the liver treatment market is segmented into open computed tomography, magnetic resonance imaging (MRI), ultrasound and other imaging modalities.In 2017, the computed tomography segment is anticipated to attain maximum share and grow at the highest CAGR during the forecast period in the liver treatment market.

A CT scan provides accurate information about the size, shape and position of any tumors in the liver or elsewhere in the abdomen, as well as nearby blood vessels.Hence, it is used to identify the location of a tumor, analyze the extent of cancer in the body and also determine whether the disease is responding to treatments.

Advantages offered by CT over other modalities is likely to make the CT dominant over other modalities in the liver treatment market.

Some of the major primary and secondary sources included in the report for the liver treatment market are World Health Organization (WHO), American Cancer Society, National Institute for Health Research, Health Ministry in British Columbia, Center for Devices and Radiological Health, Organisation for Economic Cooperation and Development, Food and Drug Administration, American Association for the Study of Liver Diseases, and Health Protection Agency among others.

Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the liver treatment market.
-Highlights key business priorities in order to assist companies to realign their business strategies.
-The key findings and recommendations highlight crucial progressive industry trends in the global liver treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
-Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
-Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
-Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Read the full report: https://www.reportlinker.com/p05626750/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...

at 18:18
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...

at 18:15
Equality Health Foundation, the philanthropic partner of Equality Health LLC and an organization dedicated to advancing health equity and improving well-being access for underserved communities, proudly announces its expansion into Virginia and...

at 18:01
Aflac Incorporated announced today that it has revised the time of its first quarter webcast teleconference call on Thursday, May 2, 2024 to 7:00 a.m. (ET), which is one hour earlier than the originally scheduled 8:00 a.m. start time, to avoid...



News published on and distributed by: